Journal of Leukocyte Biology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Originally published online as doi:10.1189/jlb.1003486 on November 21, 2003

Published online before print November 21, 2003
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jlb.1003486v1
75/3/398    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bucala, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bucala, R.
(Journal of Leukocyte Biology. 2004;75:398-399.)
© 2004 by Society for Leukocyte Biology

Series introduction: molecular and cellular basis of septic shock

Rick Bucala1

The Anlyan Center, Department of Medicine and Pathology, Yale University School of Medicine, New Haven, Connecticut

1 Correspondence: The Anlyan Center, S525, Department of Medicine and Pathology, Yale University School of Medicine, 300 Cedar St., New Haven, CT 06520. E-mail: richard.bucala{at}yale.edu

This series of overviews was contributed by participants of a Keystone Symposium, which was convened in early 2003 to address the topic of septic shock in an interdisciplinary manner. This occasion reflects a resurgence of interest in septic shock as a disease that may soon be approachable by new therapeutic interventions.

Key Words: Toll-like receptors • immunomodulatory therapy • pharmacologic therapy • cytokines






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the Society for Leukocyte Biology.